Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, Shandong, 256603, China.
Sleep Breath. 2024 Nov 26;29(1):10. doi: 10.1007/s11325-024-03206-x.
The intestinal microbiota and insomnia interact through the microbiota-gut-brain axis. The purpose of this review is to summarize and analyze the changes of intestinal microbiota in insomnia, the interaction mechanisms between intestinal microbiota and insomnia and the treatment methods based on the role of microbiota regulation in insomnia, in order to reveal the feasibility of artificial intervention of intestinal microbiota to improve insomnia.
Pubmed/ Embase were searched through March 2024 to explore the relevant studies, which included the gut microbiota characteristics of insomnia patients, the mechanisms of interaction between insomnia and gut microbiota, and the relationship between gut microbiota and insomnia treatment.
Numerous studies implicated insomnia could induce intestinal microbiota disorder by activating the immune response, the hypothalamic-pituitary-adrenal axis, the neuroendocrine system, and affecting bacterial metabolites, resulting in intestinal ecological imbalance, intestinal barrier destruction and increased permeability. The intestinal microbiota exerted an influence on the central nervous system through its interactions with intestinal neurons, releasing neurotransmitters and inflammatory factors, which in turn, can exacerbate symptoms of insomnia. Artificial interventions of gut microbiota included probiotics, traditional Chinese medicine, fecal microbiota transplantation, diet and exercise, whose main pathway of action is to improve sleep by affecting the release of neurotransmitters and gut microbial metabolites.
There is an interaction between insomnia and gut microbiota, and it is feasible to diagnose and treat insomnia by focusing on changes in the gut microbiota of patients with insomnia. Large cross-sectional studies and fecal transplant microbiota studies are still needed in the future to validate its safety and efficacy.
肠道微生物群与失眠通过微生物群-肠-脑轴相互作用。本综述的目的是总结和分析失眠患者肠道微生物群的变化、肠道微生物群与失眠之间的相互作用机制以及基于微生物群调节在失眠治疗中的作用的治疗方法,以揭示人工干预肠道微生物群改善失眠的可行性。
通过 2024 年 3 月在 Pubmed/Embase 上搜索,以探讨相关研究,包括失眠患者的肠道微生物群特征、失眠与肠道微生物群之间的相互作用机制以及肠道微生物群与失眠治疗的关系。
大量研究表明,失眠可以通过激活免疫反应、下丘脑-垂体-肾上腺轴、神经内分泌系统以及影响细菌代谢物来诱导肠道微生物群紊乱,导致肠道生态失衡、肠道屏障破坏和通透性增加。肠道微生物群通过与肠道神经元相互作用,释放神经递质和炎症因子,对中枢神经系统产生影响,从而加重失眠症状。肠道微生物群的人工干预包括益生菌、中药、粪便微生物移植、饮食和运动,其主要作用途径是通过影响神经递质和肠道微生物代谢物的释放来改善睡眠。
失眠与肠道微生物群之间存在相互作用,通过关注失眠患者肠道微生物群的变化,可以对失眠进行诊断和治疗。未来仍需要进行大规模的横断面研究和粪便移植微生物群研究,以验证其安全性和疗效。